In the antibody-drug conjugation (ADC) approach, highly toxic molecules are attached to highly specific antibodies thereby increasing their tumor cell-killing capability.
In the antibody-drug conjugation (ADC) approach, highly toxic molecules are attached to highly specific antibodies thereby increasing their tumor cell-killing capability.